IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistance through endoplasmic reticulum stress signaling pathway in triple negative breast cancer cells

ABSTRACT: We investigated how gefitinib-treatment and/or IL-26 stimulation affected gene expression in HCC70 cells by DNA microarray analysis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE171641 | GEO | 2021/04/07

REPOSITORIES: GEO